Children suffering from multisystem hyperinflammatory response post-COVID-19 have a variety of symptoms, including fever, headaches, abdominal pain, rash and conjunctivitis. In severe cases, inflammation in the walls of the blood vessels occurs, leading to toxic shock syndrome.

TOP INSIGHT
Multisystem Inflammatory Syndrome in Children (MIS-C) leads to severe symptoms like diarrhea, rash, conjunctivitis and sometimes even shock, that warrants management is pediatric intensive care unit through mechanical ventilation and support.
Read More..
The most common clinical presentation was fever, found in 33 (94%) of the children, gastrointestinal symptoms including abdominal pain, vomiting and diarrhea in 30 (86%) of the children, rash (13 or 37%) and conjunctivitis (9 or 26%). Twenty-one children (60%) were in shock. Clinical status was severe enough to warrant management in the pediatric intensive care unit in 24 of 35 children (69%), of which 7 (20%) required mechanical ventilation and 20 (57%) inotropic support.
Two children required extracorporeal membrane oxygenation (ECMO) due to severe myocardial dysfunction. Lab tests revealed that all of the children had abnormal white blood cell counts.
The study identified a pattern of imaging findings in post COVID-19 MIS-C, including airway inflammation, rapidly progressive pulmonary edema, coronary artery aneurysms and extensive abdominal inflammatory changes within the right iliac fossa.
All 35 children underwent chest X-ray due to fever, sepsis or features of multisystem inflammation. Nineteen X-rays were abnormal, the most common finding being that of bronchial wall thickening.
Abdominal ultrasound findings included inflammatory changes within the right iliac fossa, with mesenteric fat stranding, lymphadenopathy and bowel wall thickening, as well as free fluid in the pelvis.
The authors advise that future studies should include a larger group of patients, ideally utilizing multi-center databases to assess the radiological findings alongside the complex clinical course of these young patients.
Source-Eurekalert
MEDINDIA



Email




